Building on current quality and risk-management best practices, the GDP-UCI seeks to modernise and improve the distribution of vaccines and medicines by applying consensus- and evidence-based improvements and by harmonising GDP processes. The goal is one of improving patient wellbeing through the pursuit of more consistent, compatible, measurable and efficient methods.
Integrating compliance
Ultimately everyone involved with GDP has the end-goal of improving patient safety and patient outcomes. The GDP·UCI is unique in that its involvement encompasses the entire pharmaceutical supply chain. This includes actors at all levels, from manufacturers and distributors to carriers, logistics service companies, solution providers and support organisations.
Good Distribution Practice - Universal Compliance Initiative
Aimed at the entire pharmaceutical distribution chain, the GDP Universal Compliance Initiative is an industry-owned and industry-led undertaking being designed to bring certainty, consistency, and continuous improvement to the process of meeting international quality and regulatory standards for the safe, efficient and sustainable distribution of medicines and vaccines.Collaboration, Consensus and UnityTo enact meaningful industry-wide change requires individual people and individual companies to see beyond their competitive differences and work towards common goals.
